Matrix Pharma deal receives gun-jumping fine in India for unauthorized changes
Matrix Pharma and associated parties have been fined by the Competition Commission of India for "gun-jumping" after making unauthorized changes to a previously approved acquisition structure. The CCI noted the changes...To view the full article, register now.
Already a subscriber? Click here to view full article